The Centers for Medicare & Medicaid Services this week proposed changes to the Medicaid Drug Rebate Program intended to improve manufacturer data integrity and help states verify drug prices. CMS will accept comments on the proposed rule through July 25. 

Related News Articles

Headline
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost…
Headline
The Centers for Medicare & Medicaid Services March 15 announced flexibilities to help states initiate interim Medicaid payments to health care providers…
Headline
The Senate voted 75-22 on March 8 to pass and send to the president for his signature a package of six appropriations bills funding certain federal agencies…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…
Headline
The House March 6 voted 339-85 to pass a package of six appropriations bills that would fund certain federal agencies through fiscal year 2024 and contains…
Headline
The House and Senate Appropriations Committees March 3 released a package of six appropriations bills that would fund certain federal agencies through fiscal…